— Know what they know.
Not Investment Advice

AOBI OTC

American Oriental Bioengineering, Inc.
1W: +0.0% 1M: +0.0% 3M: +983.3% YTD: +983.3% 1Y: +1081.8% 3Y: +6400.0% 5Y: -99.5%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $949 mcap · 56295 float · 1.52% daily turnover

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 22 Grade D
Profitability
5
Balance Sheet
8
Earnings Quality
34
Growth
50
Value
34
Momentum
51
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. AOBI scores highest in Momentum (51/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-0.44
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
-3.44
Unlikely Manipulator
Ohlson O-Score
-5.87
Bankruptcy prob: 0.3%
Low Risk
Credit Rating
CCC
Score: 18.5/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.34x
Accruals: -12.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. AOBI scores -0.44, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. AOBI scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. AOBI's score of -3.44 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. AOBI's implied 0.3% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. AOBI receives an estimated rating of CCC (score: 18.5/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
0.00x
P/S
0.00x
P/B
0.00x
P/FCF
-0.07x
P/OCF
—
EV/EBITDA
-1.31x
EV/Revenue
0.77x
EV/EBIT
-1.12x
EV/FCF
-1.57x
Earnings Yield
-2214.30%
FCF Yield
-1451.21%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. AOBI currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.023
NI / EBT
×
Interest Burden
1.065
EBT / EBIT
×
EBIT Margin
-0.687
EBIT / Rev
×
Asset Turnover
0.262
Rev / Assets
×
Equity Multiplier
1.438
Assets / Equity
=
ROE
-28.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. AOBI's ROE of -28.2% is driven by Asset Turnover (0.262), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.02 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.01
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
570.7%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
ROE 14.5% 13.3% 12.3% 10.5% 11.2% 9.9% 7.7% 6.0% 3.7% 3.1% 2.5% 3.2% -16.6% -21.3% -28.8% -25.0% -16.8% -18.9% -15.7% -28.2% -28.19%
ROA 10.9% 10.2% 9.4% 7.1% 7.5% 6.8% 5.3% 4.1% 2.6% 2.2% 1.7% 2.2% -11.5% -14.7% -19.6% -18.0% -11.8% -13.1% -10.7% -19.6% -19.60%
ROIC 12.7% 12.2% 12.4% 10.8% 10.3% 9.4% 7.6% 6.1% 4.3% 3.8% 2.7% 3.3% -8.1% -12.2% -17.9% -23.5% -17.6% -19.6% -17.2% -16.5% -16.54%
ROCE 16.0% 15.5% 15.0% 13.2% 11.5% 10.6% 8.7% 7.2% 5.2% 5.0% 4.6% 4.5% -15.1% -21.4% -31.1% -36.6% -26.7% -29.9% -26.6% -27.7% -27.73%
Gross Margin 62.4% 61.7% 58.4% 56.0% 52.6% 52.5% 51.5% 51.7% 50.9% 48.2% 47.8% 46.7% 44.8% 29.8% 11.6% 21.9% 43.3% 21.4% 24.7% 17.3% 17.33%
Operating Margin 12.3% 23.6% 25.3% 19.0% 14.9% 11.9% 11.8% 9.8% 7.1% 10.7% 11.6% 10.2% -1.2% -58.6% -81.0% -65.1% -47.8% -90.5% -51.0% -1.1% -1.06%
Net Margin 8.4% 15.5% 17.6% 12.7% 11.7% 5.8% 6.6% 4.6% 3.3% 1.6% 5.0% 14.2% -1.5% -66.6% -94.0% 64.8% -57.5% -1.0% -63.5% -1.2% -1.18%
EBITDA Margin 28.7% 28.4% 29.8% 22.6% 20.1% 18.1% 15.7% 12.2% 11.1% 16.4% 19.4% 19.3% -1.5% -46.5% -70.4% -55.7% -50.0% -80.8% -35.8% -89.3% -89.25%
FCF Margin -35.9% -37.6% -34.4% -22.4% 6.9% 7.2% 0.5% -6.1% 0.6% 4.3% -0.4% 4.7% -9.4% -33.4% -43.3% -60.1% -50.0% -34.4% -24.8% -49.1% -49.06%
OCF Margin 29.4% 26.0% 26.7% 25.1% 8.6% 9.1% 2.1% -3.6% 2.6% 7.8% 4.4% 8.8% 14.1% -7.1% -10.4% -20.7% -32.0% -19.0% -12.7% -25.7% -25.70%
ROE 3Y Avg snapshot only -19.11%
ROE 5Y Avg snapshot only -8.34%
ROA 3Y Avg snapshot only -13.18%
ROIC 3Y Avg snapshot only -11.21%
ROIC Economic snapshot only -16.50%
Cash ROA snapshot only -7.31%
Cash ROIC snapshot only -8.37%
CROIC snapshot only -15.98%
NOPAT Margin snapshot only -50.77%
Pretax Margin snapshot only -73.16%
R&D / Revenue snapshot only 6.29%
SGA / Revenue snapshot only 52.65%
SBC / Revenue snapshot only 1.64%
Valuation
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
P/E Ratio 3.10 1.84 2.65 2.86 2.54 2.44 1.60 1.89 2.99 2.19 2.02 0.86 -0.16 -0.18 -0.13 -0.14 -0.24 -0.06 -0.11 -0.05 -0.000
P/S Ratio 0.56 0.31 0.41 0.37 0.36 0.30 0.15 0.14 0.15 0.09 0.08 0.05 0.05 0.08 0.09 0.11 0.10 0.03 0.04 0.03 0.000
P/B Ratio 0.43 0.24 0.32 0.28 0.27 0.23 0.12 0.11 0.11 0.07 0.05 0.03 0.03 0.04 0.04 0.04 0.04 0.01 0.02 0.01 0.000
P/FCF -1.56 -0.82 -1.20 -1.65 5.19 4.20 30.11 -2.31 23.35 2.16 -20.46 1.05 -0.53 -0.24 -0.22 -0.18 -0.19 -0.08 -0.17 -0.07 -0.069
P/OCF 1.91 1.19 1.55 1.47 4.15 3.31 7.23 — 5.67 1.19 1.71 0.56 0.35 — — — — — — — —
EV/EBITDA 2.34 1.59 1.65 1.53 1.99 1.82 1.29 1.44 1.76 0.99 1.81 1.36 -1.52 -1.12 -0.92 -0.44 -0.95 -0.71 -0.88 -1.31 -1.312
EV/Revenue 0.77 0.50 0.50 0.42 0.49 0.41 0.25 0.24 0.24 0.13 0.25 0.22 0.35 0.41 0.57 0.41 0.51 0.43 0.48 0.77 0.770
EV/EBIT 2.67 1.81 1.90 1.79 2.37 2.22 1.63 1.90 2.51 1.42 2.64 2.00 -1.21 -0.95 -0.82 -0.40 -0.82 -0.63 -0.76 -1.12 -1.121
EV/FCF -2.15 -1.34 -1.46 -1.86 7.08 5.75 48.63 -3.86 38.04 3.09 -68.71 4.61 -3.73 -1.24 -1.31 -0.68 -1.03 -1.24 -1.92 -1.57 -1.570
Earnings Yield 32.2% 54.3% 37.7% 35.0% 39.3% 41.0% 62.7% 52.8% 33.5% 45.7% 49.6% 1.2% -6.4% -5.7% -7.6% -7.0% -4.2% -17.4% -9.0% -22.1% -22.14%
FCF Yield -64.0% -1.2% -83.2% -60.7% 19.3% 23.8% 3.3% -43.2% 4.3% 46.3% -4.9% 94.9% -1.9% -4.2% -4.6% -5.6% -5.2% -13.2% -5.8% -14.5% -14.51%
PEG Ratio snapshot only 0.000
Price/Tangible Book snapshot only 0.033
EV/Gross Profit snapshot only 2.364
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Current Ratio 2.88 3.52 3.76 3.69 3.79 4.18 4.33 4.26 4.68 4.88 4.06 4.78 1.23 1.03 0.88 1.01 0.90 0.72 0.65 0.51 0.513
Quick Ratio 2.59 3.06 3.35 3.37 3.57 3.72 3.90 3.88 4.39 4.28 3.52 4.28 1.11 0.86 0.73 0.79 0.70 0.51 0.45 0.35 0.350
Debt/Equity 0.37 0.36 0.34 0.34 0.33 0.32 0.31 0.29 0.29 0.28 0.28 0.27 0.31 0.33 0.36 0.19 0.21 0.20 0.21 0.33 0.327
Net Debt/Equity 0.16 0.15 0.07 0.04 0.10 0.08 0.07 0.07 0.07 0.03 0.11 0.09 0.17 0.17 0.22 0.11 0.18 0.18 0.19 0.32 0.316
Debt/Assets 0.24 0.24 0.23 0.23 0.22 0.22 0.21 0.20 0.20 0.20 0.20 0.19 0.21 0.22 0.23 0.13 0.15 0.15 0.15 0.22 0.217
Debt/EBITDA 1.45 1.47 1.46 1.63 1.80 1.88 2.11 2.32 2.92 3.01 3.17 3.20 -2.39 -1.73 -1.25 -0.53 -0.86 -0.75 -0.90 -1.30 -1.299
Net Debt/EBITDA 0.64 0.61 0.29 0.17 0.53 0.49 0.49 0.58 0.68 0.30 1.27 1.05 -1.31 -0.90 -0.77 -0.32 -0.77 -0.67 -0.80 -1.25 -1.254
Interest Coverage 2501.50 46.89 23.38 15.78 10.57 9.83 8.62 6.91 5.01 4.88 4.51 4.14 -9.29 -11.97 -15.65 -20.46 -15.54 -19.71 -20.68 -23.71 -23.708
Equity Multiplier 1.52 1.48 1.47 1.47 1.46 1.45 1.44 1.44 1.42 1.41 1.41 1.40 1.48 1.50 1.55 1.38 1.36 1.38 1.39 1.51 1.507
Cash Ratio snapshot only 0.026
Debt Service Coverage snapshot only -20.258
Cash to Debt snapshot only 0.035
FCF to Debt snapshot only -0.643
Defensive Interval snapshot only 132.4 days
Efficiency & Turnover
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Asset Turnover 0.60 0.61 0.61 0.55 0.54 0.55 0.55 0.55 0.52 0.51 0.46 0.39 0.36 0.32 0.28 0.24 0.29 0.29 0.28 0.26 0.262
Inventory Turnover 7.19 5.07 5.97 7.26 11.22 7.26 8.09 9.28 13.07 6.65 6.44 5.91 7.16 3.88 4.09 3.65 5.11 3.94 3.94 3.41 3.411
Receivables Turnover 9.90 11.78 11.66 9.35 6.29 7.12 6.31 5.46 4.44 6.06 4.38 2.64 3.18 3.75 2.94 1.85 2.94 3.32 3.49 3.50 3.495
Payables Turnover 9.59 13.37 12.41 15.89 11.23 13.06 12.08 13.65 15.81 13.54 10.74 9.29 6.78 5.98 5.36 4.93 6.09 6.02 5.90 5.22 5.223
DSO 37 31 31 39 58 51 58 67 82 60 83 138 115 97 124 197 124 110 104 104 104.4 days
DIO 51 72 61 50 33 50 45 39 28 55 57 62 51 94 89 100 71 93 93 107 107.0 days
DPO 38 27 29 23 33 28 30 27 23 27 34 39 54 61 68 74 60 61 62 70 69.9 days
Cash Conversion Cycle 50 76 63 66 58 74 73 79 87 88 106 160 112 130 145 223 136 142 135 142 141.5 days
Fixed Asset Turnover snapshot only 0.653
Operating Cycle snapshot only 211.4 days
Cash Velocity snapshot only 37.630
Capital Intensity snapshot only 3.517
Growth (YoY)
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Revenue 64.8% 56.6% 43.0% 29.5% 11.9% 11.7% 9.1% 10.3% 3.3% 0.1% -9.3% -24.6% -30.5% -38.7% -43.1% -44.4% -31.8% -24.7% -16.7% -10.2% -10.20%
Net Income 10.3% -1.6% -12.4% -31.3% -13.4% -17.9% -32.3% -36.0% -63.2% -65.4% -64.8% -42.3% -5.4% -7.6% -11.8% -8.3% 11.5% 25.5% 55.5% 11.2% 11.16%
EPS -1.8% -11.5% -22.8% -34.0% -16.5% -20.2% -20.8% -25.2% -56.0% -59.3% -65.2% -42.7% -5.5% -7.4% -11.5% -8.3% 10.5% 19.7% 52.0% 6.9% 6.92%
FCF -3.3% -3.1% -2.8% -3.3% 1.2% 1.2% 1.0% 69.8% -90.4% -39.7% -1.7% 1.6% -11.2% -5.8% -65.6% -8.1% -2.6% 22.6% 52.3% 26.7% 26.69%
EBITDA 52.1% 36.9% 20.6% -1.3% -17.2% -20.0% -30.6% -33.3% -41.4% -40.3% -34.0% -27.2% -2.2% -2.7% -3.5% -4.3% -61.8% -21.1% 27.5% 43.3% 43.31%
Op. Income 23.1% 12.2% -1.5% -22.0% -8.7% -14.2% -27.5% -29.4% -48.3% -45.6% -41.1% -40.8% -2.5% -3.2% -4.6% -6.1% -88.6% -35.9% 17.4% 34.7% 34.69%
OCF Growth snapshot only -11.69%
Asset Growth snapshot only -14.67%
Equity Growth snapshot only -21.64%
Debt Growth snapshot only 38.02%
Shares Change snapshot only -4.56%
Growth (CAGR)
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Revenue 3Y 69.1% 61.8% 55.9% 48.8% 39.2% 37.6% 34.4% 30.8% 24.0% 20.6% 12.2% 2.5% -7.0% -11.8% -17.5% -22.6% -21.2% -22.7% -24.5% -27.8% -27.77%
Revenue 5Y 66.2% 64.9% 64.8% 63.1% 56.1% 53.4% 49.4% 46.6% 41.1% 36.5% 30.2% 22.4% 14.1% 9.9% 4.6% -1.2% -2.0% -4.2% -7.7% -11.6% -11.65%
EPS 3Y 28.1% 25.7% 18.9% 5.9% 0.5% -3.1% -8.6% -14.9% -28.8% -34.0% -40.3% -34.4% — — — — — — — — —
EPS 5Y 37.3% 30.1% 27.3% 19.3% 16.5% 15.5% 9.7% 3.1% -5.0% -8.4% -14.3% -12.6% — — — — — — — — —
Net Income 3Y 52.7% 41.2% 33.4% 18.9% 12.5% 6.9% -4.6% -14.6% -29.4% -34.6% -40.7% -36.7% — — — — — — — — —
Net Income 5Y 59.7% 57.5% 55.2% 44.9% 39.7% 33.9% 23.2% 15.0% 2.6% -4.3% -10.8% -9.1% — — — — — — — — —
EBITDA 3Y 61.9% 53.1% 47.4% 35.7% 22.2% 18.5% 9.2% 1.6% -9.6% -13.2% -17.9% -21.7% — — — — — — — — —
EBITDA 5Y 64.1% 62.8% 61.3% 54.8% 43.4% 38.0% 28.9% 22.7% 15.5% 11.4% 8.0% 3.9% — — — — — — — — —
Gross Profit 3Y 70.3% 61.6% 53.5% 43.8% 32.6% 29.5% 24.5% 19.7% 12.4% 8.9% 1.1% -8.1% -16.9% -22.3% -30.4% -38.3% -35.7% -37.2% -36.1% -38.2% -38.21%
Gross Profit 5Y 67.0% 64.5% 62.2% 58.8% 51.8% 49.1% 44.5% 41.4% 35.0% 30.0% 23.4% 15.1% 6.9% 1.4% -6.9% -16.0% -16.8% -19.2% -20.6% -23.6% -23.65%
Op. Income 3Y 51.9% 42.8% 37.2% 24.4% 17.4% 12.7% 2.3% -5.8% -16.6% -19.4% -25.0% -31.1% — — — — — — — — —
Op. Income 5Y 62.4% 61.0% 58.6% 50.2% 42.4% 36.4% 26.3% 19.6% 10.6% 6.4% 2.0% -4.3% — — — — — — — — —
FCF 3Y — — — — -6.4% -3.9% -63.0% — -63.8% -35.3% — -26.5% — — — — — — — — —
FCF 5Y — — — — 19.5% 25.6% -28.0% — -19.4% 10.3% — -4.4% — — — — — — — — —
OCF 3Y 88.5% 70.5% 63.0% 47.5% -4.4% -2.5% -43.4% — -43.7% -22.5% -39.9% -31.4% -27.2% — — — — — — — —
OCF 5Y 95.5% 69.9% 79.3% 64.7% 24.8% 31.3% -4.5% — -7.1% 10.8% -6.6% -1.3% 0.6% — — — — — — — —
Assets 3Y 74.0% 59.0% 51.2% 49.8% 46.0% 44.2% 41.4% 23.9% 20.0% 18.4% 16.7% 8.2% 2.5% 1.6% -0.6% -3.8% -8.2% -9.8% -10.6% -10.9% -10.88%
Assets 5Y 89.1% 84.1% 84.9% 81.4% 68.2% 66.1% 63.1% 57.4% 43.8% 36.3% 32.1% 30.7% 25.0% 23.4% 20.6% 9.6% 4.8% 2.7% 1.1% -3.2% -3.23%
Equity 3Y 56.2% 43.1% 42.5% 39.3% 36.2% 33.8% 31.4% 15.9% 11.2% 9.7% 8.6% 10.7% 3.4% 1.2% -2.3% -1.7% -6.0% -8.3% -9.5% -12.3% -12.29%
Book Value 3Y 31.0% 27.4% 26.9% 24.1% 21.7% 21.2% 25.8% 15.6% 12.1% 10.7% 9.3% 14.9% 8.8% 4.5% 1.8% 3.3% 0.5% -1.9% -8.3% -11.2% -11.15%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Revenue Stability 0.89 0.91 0.93 0.96 0.96 0.97 0.98 0.99 0.94 0.93 0.84 0.63 0.37 0.21 0.07 0.00 0.01 0.05 0.20 0.42 0.418
Earnings Stability 0.95 0.94 0.91 0.77 0.84 0.73 0.45 0.19 0.03 0.00 0.05 0.14 0.49 0.53 0.57 0.62 0.79 0.78 0.68 0.82 0.824
Margin Stability 0.97 0.97 0.96 0.95 0.93 0.92 0.91 0.89 0.88 0.87 0.87 0.86 0.86 0.84 0.79 0.73 0.72 0.71 0.70 0.67 0.669
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.96 0.99 0.95 0.87 0.95 0.93 0.87 0.86 0.50 0.50 0.50 0.83 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.90 0.98 0.87 0.63 0.86 0.80 0.61 0.56 0.08 0.03 0.04 0.46 — — — — — — — — —
ROE Trend -0.02 -0.03 -0.05 -0.05 -0.03 -0.04 -0.06 -0.07 -0.09 -0.08 -0.07 -0.05 -0.25 -0.29 -0.38 -0.33 -0.11 -0.11 -0.01 -0.19 -0.195
Gross Margin Trend -0.02 -0.03 -0.05 -0.08 -0.11 -0.12 -0.12 -0.12 -0.09 -0.09 -0.08 -0.07 -0.07 -0.09 -0.14 -0.20 -0.19 -0.18 -0.11 -0.07 -0.069
FCF Margin Trend -0.60 -0.62 -0.60 -0.42 0.12 0.12 0.04 -0.01 0.15 0.20 0.17 0.19 -0.13 -0.39 -0.43 -0.59 -0.46 -0.20 -0.03 -0.21 -0.214
Sustainable Growth Rate 14.5% 13.3% 12.3% 10.5% 11.2% 9.9% 7.7% 6.0% 3.7% 3.1% 2.5% 3.2% — — — — — — — — —
Internal Growth Rate 12.2% 11.3% 10.4% 7.6% 8.1% 7.3% 5.6% 4.3% 2.6% 2.2% 1.8% 2.3% — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
OCF/Net Income 1.63 1.55 1.72 1.95 0.61 0.74 0.22 -0.48 0.53 1.84 1.18 1.54 -0.44 0.15 0.15 0.27 0.78 0.42 0.33 0.34 0.343
FCF/OCF -1.22 -1.44 -1.29 -0.89 0.80 0.79 0.24 1.71 0.24 0.55 -0.08 0.53 -0.66 4.71 4.15 2.91 1.56 1.80 1.95 1.91 1.909
FCF/Net Income snapshot only 0.655
CapEx/Revenue 65.3% 63.6% 61.1% 47.5% 1.7% 1.9% 1.6% 2.5% 2.0% 3.5% 4.8% 4.1% 23.4% 26.3% 32.9% 39.4% 18.0% 15.3% 12.1% 23.4% 23.37%
CapEx/Depreciation snapshot only 2.373
Accruals Ratio -0.07 -0.06 -0.07 -0.07 0.03 0.02 0.04 0.06 0.01 -0.02 -0.00 -0.01 -0.17 -0.12 -0.17 -0.13 -0.03 -0.08 -0.07 -0.13 -0.129
Sloan Accruals snapshot only -0.160
Cash Flow Adequacy snapshot only -1.100
Dividends & Buybacks
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — — — — —
FCF Payout Ratio — — — — 0.0% 0.0% 0.0% — 0.0% 0.0% — 0.0% — — — — — — — — —
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 8.5% 8.5% 8.7% 9.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 8.5% 8.5% 8.7% 9.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 8.5% 8.5% 8.7% 9.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Tax Burden (NI/EBT) 0.79 0.78 0.77 0.76 0.75 0.75 0.73 0.70 0.65 0.57 0.50 0.70 0.99 0.96 0.95 0.97 1.04 1.03 1.05 1.02 1.023
Interest Burden (EBT/EBIT) 0.79 0.78 0.77 0.73 0.91 0.89 0.87 0.86 0.80 0.79 0.77 0.75 1.11 1.08 1.07 0.77 0.63 0.64 0.58 1.06 1.065
EBIT Margin 0.29 0.28 0.26 0.23 0.21 0.19 0.15 0.12 0.10 0.09 0.10 0.11 -0.29 -0.44 -0.70 -1.02 -0.62 -0.68 -0.63 -0.69 -0.687
Asset Turnover 0.60 0.61 0.61 0.55 0.54 0.55 0.55 0.55 0.52 0.51 0.46 0.39 0.36 0.32 0.28 0.24 0.29 0.29 0.28 0.26 0.262
Equity Multiplier 1.33 1.31 1.31 1.48 1.49 1.46 1.46 1.45 1.44 1.43 1.43 1.42 1.45 1.45 1.47 1.39 1.43 1.44 1.47 1.44 1.438
Per Share
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
EPS (Diluted TTM) $548.36 $524.95 $499.17 $426.07 $457.74 $418.81 $395.57 $318.77 $201.26 $170.64 $137.81 $182.60 $-902.03 $-1084.07 $-1451.89 $-1340.70 $-807.74 $-870.52 $-696.36 $-1247.98 $-1247.98
Book Value/Share $3959.72 $4079.46 $4148.11 $4302.35 $4359.80 $4462.42 $5369.22 $5545.98 $5677.52 $5737.45 $5847.48 $5988.50 $5104.62 $4652.47 $4370.14 $4737.37 $4431.28 $4207.15 $4137.22 $3889.55 $4285.04
Tangible Book/Share $1651.59 $1782.00 $1914.38 $1964.92 $2089.25 $2183.68 $2699.81 $2868.14 $2993.25 $3063.38 $3180.37 $3318.40 $2849.10 $2514.50 $2237.18 $2518.83 $2052.21 $2048.63 $1957.30 $1717.52 $1717.52
Revenue/Share $3035.60 $3135.15 $3205.93 $3296.72 $3272.71 $3402.97 $4093.49 $4255.37 $4035.83 $4009.65 $3674.11 $3186.51 $2844.41 $2366.09 $2036.97 $1771.59 $1962.76 $1919.05 $1827.74 $1667.02 $1898.00
FCF/Share $-1088.82 $-1177.91 $-1102.40 $-738.58 $224.44 $243.45 $20.97 $-260.94 $25.74 $172.64 $-13.59 $149.71 $-266.38 $-790.92 $-881.55 $-1064.73 $-982.01 $-659.34 $-452.73 $-817.90 $-949.60
OCF/Share $891.93 $815.33 $856.57 $828.88 $280.79 $308.34 $87.29 $-152.77 $105.97 $314.68 $163.08 $281.34 $400.61 $-167.87 $-212.31 $-366.02 $-628.38 $-365.42 $-231.86 $-428.34 $-607.64
Cash/Share $810.24 $851.94 $1136.44 $1307.05 $1007.02 $1072.86 $1273.81 $1219.54 $1247.49 $1468.81 $981.20 $1087.06 $703.82 $727.26 $607.03 $345.88 $96.00 $87.72 $96.16 $44.30 $92.83
EBITDA/Share $999.45 $990.79 $971.49 $898.14 $797.20 $770.44 $789.01 $700.66 $557.67 $541.65 $515.93 $506.22 $-652.32 $-879.20 $-1263.23 $-1647.88 $-1067.50 $-1147.36 $-985.93 $-978.90 $-978.90
Debt/Share $1451.44 $1459.11 $1416.63 $1460.77 $1431.98 $1450.14 $1662.16 $1623.55 $1625.65 $1629.22 $1637.07 $1618.65 $1557.21 $1517.42 $1574.18 $879.52 $915.01 $856.92 $888.01 $1271.98 $1271.98
Net Debt/Share $641.20 $607.17 $280.19 $153.72 $424.95 $377.28 $388.35 $404.01 $378.16 $160.41 $655.87 $531.59 $853.39 $790.17 $967.15 $533.65 $819.00 $769.20 $791.85 $1227.68 $1227.68
Academic Models
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -0.441
Altman Z-Prime snapshot only -2.052
Piotroski F-Score 4 4 4 5 5 5 6 5 6 6 4 5 3 1 1 2 4 4 5 3 3
Beneish M-Score -1.46 -1.24 -2.21 -2.02 -1.77 -1.82 -1.29 -1.27 -1.98 -2.62 -2.35 -1.76 -2.81 -1.95 -1.97 -3.49 -2.95 -3.26 -3.61 -3.44 -3.435
Ohlson O-Score snapshot only -5.870
ROIC (Greenblatt) snapshot only -67.01%
Net-Net WC snapshot only $-1085.54
EVA snapshot only $-99048893.50
Credit
Metric Trend Q4'08 Q1'09 Q2'09 Q3'09 Q4'09 Q1'10 Q2'10 Q3'10 Q4'10 Q1'11 Q2'11 Q3'11 Q4'11 Q1'12 Q2'12 Q3'12 Q4'12 Q1'13 Q2'13 Q3'13 Current
Credit Rating snapshot only CCC
Credit Score 77.29 76.99 77.30 75.90 75.41 73.19 58.89 54.85 55.94 54.23 49.99 53.64 33.96 28.08 20.98 22.87 20.62 20.03 18.20 18.52 18.522
Credit Grade snapshot only 17
Credit Trend snapshot only -4.348
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 12
Sector Credit Rank snapshot only 8

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms